Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.530
-0.080 (-4.97%)
At close: Oct 2, 2026, 4:00 PM EDT
1.700
+0.170 (11.10%)
After-hours: Oct 2, 2026, 7:49 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $277.05 million as of October 2, 2026. Its market cap has increased by 541.65% in one year.
Market Cap
277.05M
Enterprise Value
196.00M
1-Year Change
541.65%
Ranking
Category
Stock Price
$1.53
ChartMarket Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $277.05M, a decrease of -73.64%. That is a compound annual growth rate of -22.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 277.05M | 218.96% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 315.08M |
| Indaptus Therapeutics | 314.45M |
| Evommune | 306.31M |
| Vanda Pharmaceuticals | 299.89M |
| Abeona Therapeutics | 298.50M |
| SAB Biotherapeutics | 297.98M |
| Clinuvel Pharmaceuticals | 294.75M |
| EyePoint | 288.38M |